Immunogenicity of RV1 and RV5 vaccines administered in standard and interchangeable mixed schedules: a randomized, double-blind, non-inferiority clinical trial in Mexican infants

• প্রধান লেখক: Mercedes Macías-Parra (লেখক), Patricia Vidal-Vázquez (লেখক), Jesús Reyna-Figueroa (লেখক), Miguel Ángel Rodríguez-Weber (লেখক), Hortensia Moreno-Macías (লেখক), Inés Hernández-Benavides (লেখক), Sofía Fortes-Gutiérrez (লেখক), Vesta Louise Richardson (লেখক), Paola Vázquez-Cárdenas (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Frontiers Media S.A., 2024-02-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

IntroductionRotavirus-associated diarrheal diseases significantly burden healthcare systems, particularly affecting infants under five years. Both Rotarix™ (RV1) and RotaTeq™ (RV5) vaccines have been effective but have distinct application schedules and limited interchangeability data. This study ai...